Electrophysiology

The RHYTHMIA HDx™ Mapping System offers industry-defining cardiac mapping, a powerful analysis toolset designed to streamline targeting and clinical decision-making, and unique insights into tissue substrate and lesion formation during RF ablation. Combining intelligence without complexity, the system helps physicians diagnose with greater efficiency and deliver targeted therapy. The RHYTHMIA HDx Mapping System is now available with DIRECTSENSE Technology, which features a unique local impedance measure that reveals powerful insights into tissue resistivity and subsurface heating during radiofrequency ablation procedures.

The proprietary puncture technology of the VersaCross RF Transseptal Solution enables safe and reliable left heart access to deliver critical cardiac therapies. By using RF energy instead of conventional mechanical needles, left heart access has become more predictable, with reduced rates of serious complications. The platform reimagines left heart access by reducing device exchanges during a procedure, while still using standard-of-care RF puncture technology.

The FARAPULSE PFA System was purposefully built from the ground up to deliver PFA therapy and is optimized through extensive preclinical and clinical studies. It uses a novel, non-thermal method for cardiac ablation that is fundamentally different from traditional modalities, which ablate indiscriminately. Because it is tissue selective, the FARAPULSE PFA System enables physicians to ablate cardiac tissue while minimizing procedural complications, such as impact to surrounding structures.^6,7

The POLARx Cryoablation System is designed to provide greater physician control and increased procedural predictability during cardiac ablations. Combining a modernized console, balloon catheter, steerable sheath and circular mapping catheter, the POLARx System creates a direct path to pulmonary vein isolation while providing safe, efficient and effective treatment of atrial fibrillation.